| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/07853899009147243 |
| P8608 | Fatcat ID | release_t2u6bq4agnhdbpidwsqmupprta |
| P698 | PubMed publication ID | 2184848 |
| P2093 | author name string | Vapaatalo H | |
| Gordin A | |||
| Kirkkola AL | |||
| Salminen S | |||
| Saxelin M | |||
| Siitonen S | |||
| Wikberg R | |||
| P2860 | cites work | Erythromycin acistrate and erythromycin stearate in the treatment of non-gonococcal urethritis | Q37899934 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | yogurt | Q13317 |
| diarrhea | Q40878 | ||
| P304 | page(s) | 57-59 | |
| P577 | publication date | 1990-02-01 | |
| P1433 | published in | Annals of Medicine | Q4767853 |
| P1476 | title | Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea | |
| P478 | volume | 22 |
| Q52061556 | A randomized clinical trial of the effect of yoghurt on the human salivary microflora |
| Q42114946 | Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? |
| Q36062992 | Administration of different Lactobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora. |
| Q79218992 | American Association of Clinical Endocrinologists Medical Guidelines for the Clinical Use of Dietary Supplements and Nutraceuticals |
| Q28288674 | Analysis of Lactobacillus phages and bacteriocins in American dairy products and characterization of a phage isolated from yogurt |
| Q35890738 | Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens |
| Q34737893 | Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection |
| Q24806569 | Artificial Cell Therapy: New Strategies for the Therapeutic Delivery of Live Bacteria |
| Q41393552 | Bacillus amyloliquefaciens as prophylactic treatment for Clostridium difficile-associated disease in a mouse model |
| Q43678916 | Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients |
| Q34391564 | Biotherapeutic agents in the treatment of infectious diarrhea |
| Q41148188 | Biotherapy for antibiotic-associated and other diarrhoeas |
| Q34586857 | Clinical indications for probiotics: an overview |
| Q40924251 | Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges |
| Q46324386 | Close association between intestinal microbiota and irritable bowel syndrome |
| Q34507971 | Detection and characterization of Bifidobacterium crudilactis and B. mongoliense able to grow during the manufacturing process of French raw milk cheeses |
| Q26991504 | Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent |
| Q35596086 | Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of salmonella in rats |
| Q33869477 | Do probiotics have a therapeutic role in gastroenterology? |
| Q42772339 | Do probiotics prevent childhood illnesses? |
| Q73565856 | Effect of Lactobacillus-fermented diets on bacterial translocation and intestinal flora in experimental prehepatic portal hypertension |
| Q24655137 | Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial |
| Q40858584 | Effect of consumption of lactic cultures on human health. |
| Q33887948 | Effect of lactic acid bacteria on diarrheal diseases |
| Q24628564 | Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial |
| Q38114508 | Encapsulation of Probiotic Bacteria in Biopolymeric System |
| Q39583627 | Fermentation of fructooligosaccharides by lactic acid bacteria and bifidobacteria |
| Q35134579 | Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis |
| Q34835307 | Gut bacteria and health foods--the European perspective |
| Q50134113 | Inhibition ofSalmonella typhimuriumadhesion to Caco-2 cell cultures byLactobacillusstrain GG spent culture supernate: only a pH effect? |
| Q35835072 | Interactions between Lactobacilli and antibiotic-associated diarrhea |
| Q36801834 | Intestinal Protective Effects of Herbal-Based Formulations in Rats against Neomycin Insult |
| Q53629667 | Isolation and characterization of lactobacilli from human faeces and indigenous fermented foods for their potential application as probiotics |
| Q50117292 | Isolation of human faecal bifidobacteria which reduce signs of Salmonella infection when orogastrically dosed to mice |
| Q83873005 | Lactobacillus GG does not affect D-lactic acidosis in diarrheic calves, in a clinical setting |
| Q29028534 | Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children |
| Q36522487 | Lactobacillus GG vaginal suppositories and vaginitis |
| Q43930057 | Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability |
| Q41835733 | Lactobacillus rhamnosus strain GG is a potential probiotic for calves |
| Q40777212 | Manipulation of the human gut microflora |
| Q47858003 | Meta‐analysis: probiotics in antibiotic‐associated diarrhoea |
| Q37983881 | Milk, milk products, and disease free health: an updated overview. |
| Q54458413 | Mixed culture fermentation studies on the effects of synbiotics on the human intestinal pathogens Campylobacter jejuni and Escherichia coli. |
| Q63391480 | Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone |
| Q36522478 | PCR for detection of Pneumocystis carinii in blood cells. |
| Q34472684 | Preclinical and Clinical Pharmacology of Biotherapeutic Agents:Saccharomyces boulardii |
| Q33945722 | Probiotic agents and infectious diseases: a modern perspective on a traditional therapy |
| Q34133456 | Probiotic bacteria: safety, functional and technological properties |
| Q37094595 | Probiotic products in Canada with clinical evidence: what can gastroenterologists recommend? |
| Q34820531 | Probiotics as modulators of the gut flora |
| Q42470900 | Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials |
| Q33464907 | Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial |
| Q24202700 | Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children |
| Q46236620 | Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. |
| Q91644124 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q24186991 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q24235039 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q24245196 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q78452767 | Probiotics in antibiotic-associated diarrhoea |
| Q24529831 | Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis |
| Q92876444 | Probiotics in the next-generation sequencing era |
| Q35542625 | Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans |
| Q34156354 | Probiotics--snake oil for the new millennium? |
| Q39389296 | Probiotics: Functionality and commercial status |
| Q34197047 | Prophylactic and therapeutic uses of probiotics: a review |
| Q33870171 | Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients |
| Q40840258 | Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease |
| Q33736490 | Review of probiotics available to modify gastrointestinal flora. |
| Q34094620 | Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis |
| Q29013282 | Saccharomyces boulardii'. A Review of an Innovative Biotherapeutic Agent |
| Q47150066 | Scientific Opinion on the substantiation of a health claim related toLactobacillus rhamnosusGG and maintenance of defence against pathogenic gastrointestinal microorganisms pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| Q47153405 | Scientific Opinion on the substantiation of a health claim related toLactobacillus rhamnosusGG and maintenance of normal defecation during antibiotic treatment pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| Q41396772 | Selective detection, enumeration and identification of potentially probiotic Lactobacillus and Bifidobacterium species in mixed bacterial populations |
| Q33826454 | Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. |
| Q37365306 | Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread |
| Q35144567 | The Enteric Two-Step: nutritional strategies of bacterial pathogens within the gut |
| Q43352809 | The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin |
| Q58228933 | The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy |
| Q43233894 | The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity |
| Q24548346 | The scientific basis for probiotic strains of Lactobacillus |
| Q30829944 | The yin and yang of bacterial resilience in the human gut microbiota |
| Q34105498 | Treatment and prevention of antibiotic associated diarrhea |
| Q34180145 | Treatment of infectious diarrhea in children |
| Q77308995 | Use of Probiotics in Childhood Gastrointestinal Disorders |
| Q35202871 | Using probiotics and prebiotics to improve gut health |
Search more.